ClinicalTrials.gg
Drug

Apalutamide clinical trials

Also written ARN-509, JNJ-56021927 and Erleada.

studies test it
85
open now
15
in phase 3
16
first study started
2010

How each study uses apalutamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the apalutamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Feb 2018 · ERLEADA · NDA 210951 (FDA, Drugs@FDA)
European Union
14 Jan 2019 · Erleada · EMEA/H/C/004452 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Apalutamide
68
Apalutamide 60mg Tab
3

Brand

Erleada
18

Development codes

ARN-509
39
JNJ-56021927
33

Studies by the year they started

85 studies that test it; most in 2020 (13)

Studies that test apalutamide, by start year
YearStudies
20101
20135
20145
20154
20169
201711
20188
20199
202013
20217
20223
20235
20244
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
21
Phase 2
45
Phase 3
16
Phase 4
2
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 31 · Other 54

Aragon Pharmaceuticals, Inc. (15) · Janssen Research & Development, LLC (8) · M.D. Anderson Cancer Center (6) · Dana-Farber Cancer Institute (4) · Janssen Pharmaceutical K.K. (3) · NRG Oncology (3) · University of Washington (3) · Jonsson Comprehensive Cancer Center (2)

Often tested with

Tested in the same studies.

Abiraterone (16) · Abiraterone Acetate (13) · Prednisone (8) · Enzalutamide (5) · Antiandrogen Therapy (4) · Docetaxel (4) · Gonadotropin-releasing Hormone Analog (3) · Bicalutamide (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 10, 5 in phase 3

Studies that test apalutamide, phase 3 first.

Studies

Open first, then newest update. How each study uses apalutamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 85

See all 85 studies that test apalutamide →

Given beside what is tested · 23 — apalutamide is usual care or a partner of the new treatment

Showing 20 of 23.

As the comparator · 2 — what is tested is compared with apalutamide

Codes

What other systems call apalutamide · ClinicalTrials.gg INT006056

  • MeSH (NLM) C572045apalutamideOne source ClinicalTrials.gov
  • UNII (FDA) 4T36H88UA7APALUTAMIDEConfirmed FDA, Wikidata
  • RxNorm 1999574Confirmed FDA, Wikidata
  • Wikidata Q21098975apalutamideConfirmed FDA, Wikidata
  • NCI Thesaurus C92574ApalutamideOne source FDA
  • DrugBank DB11901One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.